心房颤动(AF),全球最普遍的持续性心律失常,显著增加认知功能障碍的风险,中风,慢性心力衰竭,和突然的心血管死亡。聚集研究强调了遗传决定因素在AF的发生和延续中的关键作用。然而,由于明显的遗传异质性,考虑AF的遗传缺陷在很大程度上仍然不确定。这里,通过使用遗传标记进行全基因组基因分型,并在患有AF的家庭中进行连锁分析,一个新的AF致病基因座位于人类染色体7p14.2-p14.3,标记D7S526和D7S2250之间的间隔为〜4.89cM(〜4.43-Mb)。一个外显子组范围的测序分析揭示了,在定义的基因座上,TBX20基因的突变,NM_001077653.2:c.695A>G;p.(His232Arg),在家庭中完全与AF共同隔离。此外,在另一个患有AF的家庭中,TBX20的Sanger测序分析发现了一种新的突变,NM_001077653.2:c.862G>C;p.(Asp288His)。在600个无关的对照个体中均未观察到两种突变。功能研究表明,这两种突变均显着降低了靶基因KCNH2(一种公认的引起AF的基因)的反式激活和结合KCNH2启动子的能力,而它们对TBX20的核分布没有影响。最后,这些发现揭示了人类染色体7p14.2-p14.3处的一个新的AF致病位点,并强烈表明TBX20是一种新的AF易感基因,阐明房颤的潜在机制,并提示对房颤患者的等位基因特异性治疗的临床意义。
Atrial fibrillation (AF), the most prevalent type of sustained cardiac dysrhythmia globally, confers strikingly enhanced risks for cognitive dysfunction, stroke, chronic cardiac failure, and sudden cardiovascular demise. Aggregating studies underscore the crucial roles of inherited determinants in the occurrence and perpetuation of AF. However, due to conspicuous genetic heterogeneity, the inherited defects accounting for AF remain largely indefinite. Here, via whole-genome genotyping with genetic markers and a linkage assay in a family suffering from AF, a new AF-causative locus was located at human chromosome 7p14.2-p14.3, a ~4.89 cM (~4.43-Mb) interval between the markers D7S526 and D7S2250. An exome-wide sequencing assay unveiled that, at the defined locus, the mutation in the TBX20 gene, NM_001077653.2: c.695A>G; p.(His232Arg), was solely co-segregated with AF in the family. Additionally, a Sanger sequencing assay of TBX20 in another family suffering from AF uncovered a novel mutation, NM_001077653.2: c.862G>C; p.(Asp288His). Neither of the two mutations were observed in 600 unrelated control individuals. Functional investigations demonstrated that the two mutations both significantly reduced the transactivation of the target gene KCNH2 (a well-established AF-causing gene) and the ability to bind the promoter of KCNH2, while they had no effect on the nuclear distribution of TBX20. Conclusively, these findings reveal a new AF-causative locus at human chromosome 7p14.2-p14.3 and strongly indicate TBX20 as a novel AF-predisposing gene, shedding light on the mechanism underlying AF and suggesting clinical significance for the allele-specific treatment of AF patients.